Jasbir Seehra
Director, Eloxx Pharmaceuticals, Inc.
Companies
- Keros Therapeutics, Inc.Board member Apr 7, 2020 to now1
- Keros Therapeutics, Inc.Chief executive officer Apr 7, 2020 to now1
- Eloxx Pharmaceuticals, Inc.Board member Mar 5, 2018 to Jun 17, 20222
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Keros Therapeutics, Inc. KROS440,708 shares3$4.9M at $11.04Apr 2, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Apr 2, 2026Exercised options 55,000 shares at $0.30 of Keros Therapeutics, Inc.3
- Feb 19, 2026Sold 7,015 shares at $16.17 of Keros Therapeutics, Inc.4
- Sep 3, 2025Granted 90,500 shares of Keros Therapeutics, Inc.5
- Apr 4, 2025Exercised options 49,367 shares at $0.30 of Keros Therapeutics, Inc.6
- Apr 8, 2023Exercised options 4,000 shares at $0.48 of Keros Therapeutics, Inc.7
- Jun 9, 2022Exercised options 5,000 shares at $0.30 of Keros Therapeutics, Inc.8
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4SEC EDGARForm 4 filed Feb 20, 2026
- 5SEC EDGARForm 4 filed Sep 5, 2025
- 6SEC EDGARForm 4 filed Apr 7, 2025
- 7SEC EDGARForm 4 filed Apr 11, 2023
- 8SEC EDGARForm 4 filed Jun 10, 2022